IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/singapore-medical-group-ltd" target="_blank" data-smartkarma-citation="entities:7441:1" rel="noopener">Singapore Medical (SMG SP)</a>'s voluntary conditional offer from management (chairman, CEO, exec director) at S$0.37 cash per share or one new share in the offeror will close on 1 November.</li>
<li>The 90% minimum acceptance condition will not be lowered. Irrevocables remain at 51.67% of outstanding shares. The offeree circular will be despatched by 18 October.</li>
<li>The offer is underwhelming and will struggle to hit the 90% minimum acceptance condition. With shares trading in line with the offer, take profits and head for the exit.</li>
</ul>



Singapore Medical (SMG SP)'s voluntary conditional offer from management (chairman, CEO, exec director) at S$0.37 cash per share or one new share in the offeror will close on 1 November.
The 90% minimum acceptance condition will not be lowered. Irrevocables remain at 51.67% of outstanding shares. The offeree circular will be despatched by 18 October.
The offer is underwhelming and will struggle to hit the 90% minimum acceptance condition. With shares trading in line with the offer, take profits and head for the exit.


Singapore Medical’s VGO Acceptance Condition Fixed at 90%

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

Singapore Listed Healthcare Providers Expanding Across Asia

Clearbridge Health – A Play on Asia’s Precision Medicine Market

SGX Healthcare Index Outperformed Asian Benchmark in YTD

Special Situations, Content Strategist, Smartkarma

Crispin Francis

Special Situations, Content Strategist

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

On 16 February 2017, <a href="https://www.smartkarma.com/entities/9984" target="_blank" data-smartkarma-citation="entities:9984:1">Oue Ltd (OUE SP)</a> made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in <a href="https://www.smartkarma.com/entities/562" target="_blank" data-smartkarma-citation="entities:562:1">International Healthway Corporation Ltd (IHC SP)</a>. The MGO was triggered after OUE entered into an S&amp;P agreement with Ching Chiat Kwong, Low See Ching, Low Bee Lan Audrey and Tee Wee Sien (collectively, the "Vendors") for the purchase of 593.5m shares at SGD 0.106 / share. This Acquisition will be completed by way of married deals.Post completion, OUE will hold an aggregate of 995.7m shares of IHC, representing a 57.60% stake.IHC has been suspended from trading since 14 February 2017 and has yet to resume trading.

On 16 February 2017, Oue Ltd (OUE SP) made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in International Healthway Corporation Ltd (IHC SP). The MGO was triggered after OUE entered into an S&amp;P agreement with Ching Chiat Kwong, Low See Ching, Low Bee Lan Audrey and Tee Wee Sien (collectively, the "Vendors") for the purchase of 593.5m shares at SGD 0.106 / share. This Acquisition will be completed by way of married deals.Post completion, OUE will hold an aggregate of 995.7m shares of IHC, representing a 57.60% stake.IHC has been suspended from trading since 14 February 2017 and has yet to resume trading. 

International Healthway - OUE Buys a Controlling Stake Leading to an MGO

Singapore

Healthway Medical Group provides comprehensive outpatient medical services, including family medicine, health screenings, specialist consultations, dental, and allied healthcare. The group operates a wide network of clinics and medical centers offering primary care, telemedicine, and various specialized treatments. Headquartered in Singapore, the company was founded in 1990.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Healthway Medical Group (HMED SP)

Singapore Medical’s VGO Acceptance Condition Fixed at 90%

The offer is underwhelming and will struggle to hit the 90% minimum acceptance condition. With shares trading in line with the offer, take profits...

Arun George

Singapore Listed Healthcare Providers Expanding Across Asia

Singapore Exchange Ltd (SGX)

Clearbridge Health – A Play on Asia’s Precision Medicine Market

Singapore Exchange Ltd (SGX)

SGX Healthcare Index Outperformed Asian Benchmark in YTD

Singapore Exchange Ltd (SGX)

International Healthway - OUE Buys a Controlling Stake Leading to an MGO

On 16 February 2017, Oue Ltd (OUE SP) made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in International...

Crispin Francis

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)